{"id":17991,"date":"2026-10-15T14:58:46","date_gmt":"2026-10-15T12:58:46","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=17991"},"modified":"2026-10-15T14:58:46","modified_gmt":"2026-10-15T12:58:46","slug":"3-questions-a-markus-isenmann-country-lead-sanofi-suisse","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/","title":{"rendered":"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"900\" src=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-1200x900.jpg\" alt=\"\" class=\"wp-image-17992\" srcset=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-1200x900.jpg 1200w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-800x600.jpg 800w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-768x576.jpg 768w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-1536x1152.jpg 1536w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-2048x1536.jpg 2048w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n\n\n\n<h2 id=\"h-vous-dirigez-sanofi-suisse-en-tant-que-country-lead-qu-est-ce-qui-vous-motive-personnellement-dans-ce-role-et-quelle-est-votre-vision-de-la-contribution-de-sanofi-au-systeme-de-sante-en-suisse\" class=\"wp-block-heading\">Vous dirigez Sanofi Suisse en tant que Country Lead. Qu&rsquo;est-ce qui vous motive personnellement dans ce r\u00f4le, et quelle est votre vision de la contribution de Sanofi au syst\u00e8me de sant\u00e9 en Suisse ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Je suis anim\u00e9 par la conviction que le progr\u00e8s m\u00e9dical ne remplit son v\u00e9ritable objectif que lorsqu&rsquo;il atteint les personnes qui en ont besoin. Chez Sanofi, nous nous engageons dans les domaines de l&rsquo;immunologie, des maladies rares et des vaccins. Ma vision est celle d&rsquo;une Suisse o\u00f9 les patientes et les patients ont rapidement acc\u00e8s \u00e0 de nouvelles options th\u00e9rapeutiques \u2013 et o\u00f9 nous, en tant que Sanofi, y contribuons activement.<\/p>\n\n\n\n<h2 id=\"h-l-industrie-pharmaceutique-suisse-est-soumise-a-une-pression-croissante-en-raison-des-systemes-internationaux-de-referencement-des-prix-quelles-en-sont-selon-vous-les-consequences-sur-l-acces-des-patients-et-que-faut-il-pour-consolider-la-position-de-la-suisse-en-tant-que-site-leader-des-sciences-de-la-vie\" class=\"wp-block-heading\">L&rsquo;industrie pharmaceutique suisse est soumise \u00e0 une pression croissante en raison des syst\u00e8mes internationaux de r\u00e9f\u00e9rencement des prix. Quelles en sont, selon vous, les cons\u00e9quences sur l&rsquo;acc\u00e8s des patients, et que faut-il pour consolider la position de la Suisse en tant que site leader des sciences de la vie ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La Suisse dispose de l&rsquo;un des syst\u00e8mes de sant\u00e9 les plus innovants au monde \u2013 et pourtant, les patientes et les patients rencontrent des difficult\u00e9s croissantes \u00e0 acc\u00e9der en temps voulu \u00e0 de nouvelles th\u00e9rapies. Un dialogue constructif entre toutes les parties prenantes est essentiel pour trouver des solutions qui garantissent \u00e0 la fois l&rsquo;acc\u00e8s aux innovations m\u00e9dicales et la viabilit\u00e9 financi\u00e8re \u00e0 long terme du syst\u00e8me. Car, selon mon avis, les nouvelles th\u00e9rapies ne sont pas des facteurs de co\u00fbts \u2013 elles sont un investissement dans la sant\u00e9 de la population et dans l&rsquo;avenir du syst\u00e8me de sant\u00e9.<\/p>\n\n\n\n<h2 id=\"h-en-tant-que-membre-du-market-committee-d-interpharma-quelles-sont-vos-priorites-et-ou-voyez-vous-les-plus-grandes-opportunites\" class=\"wp-block-heading\">En tant que membre du Market Committee d&rsquo;Interpharma : quelles sont vos priorit\u00e9s, et o\u00f9 voyez-vous les plus grandes opportunit\u00e9s ?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pour moi, l&rsquo;\u00e9change ouvert est au premier plan \u2013 port\u00e9 par une volont\u00e9 commune de d\u00e9velopper des solutions pragmatiques qui profitent \u00e0 l&rsquo;ensemble du syst\u00e8me de sant\u00e9. La plus grande opportunit\u00e9 r\u00e9side dans la capacit\u00e9 \u00e0 faire de la Suisse un site o\u00f9 progr\u00e8s m\u00e9dical et viabilit\u00e9 financi\u00e8re durable ne s&rsquo;opposent pas, mais se renforcent mutuellement.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vous dirigez Sanofi Suisse en tant que Country Lead. Qu&rsquo;est-ce qui vous motive personnellement dans ce r\u00f4le, et quelle est votre vision de la contribution de Sanofi au syst\u00e8me de sant\u00e9 en Suisse ? Je suis anim\u00e9 par la conviction que le progr\u00e8s m\u00e9dical ne remplit son v\u00e9ritable objectif que lorsqu&rsquo;il atteint les personnes qui [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":17992,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[127],"class_list":["post-17991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-acces-des-patients"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.6 (Yoast SEO v28.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse\" \/>\n<meta property=\"og:description\" content=\"Vous dirigez Sanofi Suisse en tant que Country Lead. Qu&rsquo;est-ce qui vous motive personnellement dans ce r\u00f4le, et quelle est votre vision de la contribution de Sanofi au syst\u00e8me de sant\u00e9 en Suisse ? Je suis anim\u00e9 par la conviction que le progr\u00e8s m\u00e9dical ne remplit son v\u00e9ritable objectif que lorsqu&rsquo;il atteint les personnes qui [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T12:58:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lukaskuemmerli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"lukaskuemmerli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/\"},\"author\":{\"name\":\"lukaskuemmerli\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\"},\"headline\":\"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse\",\"datePublished\":\"2026-10-15T12:58:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/\"},\"wordCount\":366,\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"keywords\":[\"Acc\u00e8s des patients\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/\",\"name\":\"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"datePublished\":\"2026-10-15T12:58:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Bild_Markus_Isenmann_4zu3-scaled.jpg\",\"width\":2560,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/2854d813965ba4a7feaeffbe96f8eadf\",\"name\":\"lukaskuemmerli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g\",\"caption\":\"lukaskuemmerli\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/","og_locale":"fr_FR","og_type":"article","og_title":"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse","og_description":"Vous dirigez Sanofi Suisse en tant que Country Lead. Qu&rsquo;est-ce qui vous motive personnellement dans ce r\u00f4le, et quelle est votre vision de la contribution de Sanofi au syst\u00e8me de sant\u00e9 en Suisse ? Je suis anim\u00e9 par la conviction que le progr\u00e8s m\u00e9dical ne remplit son v\u00e9ritable objectif que lorsqu&rsquo;il atteint les personnes qui [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/","og_site_name":"Interpharma","article_published_time":"2026-10-15T12:58:46+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","type":"image\/jpeg"}],"author":"lukaskuemmerli","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"lukaskuemmerli","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/"},"author":{"name":"lukaskuemmerli","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf"},"headline":"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse","datePublished":"2026-10-15T12:58:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/"},"wordCount":366,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","keywords":["Acc\u00e8s des patients"],"inLanguage":"fr-FR","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/","name":"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","datePublished":"2026-10-15T12:58:46+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/10\/Bild_Markus_Isenmann_4zu3-scaled.jpg","width":2560,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-markus-isenmann-country-lead-sanofi-suisse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"3 questions \u00e0 Markus Isenmann, Country Lead Sanofi Suisse"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/2854d813965ba4a7feaeffbe96f8eadf","name":"lukaskuemmerli","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3bfeac2b6c479264ad184573779a451a81113f9e7cbabe607006461ca783d10?s=96&d=mm&r=g","caption":"lukaskuemmerli"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=17991"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17991\/revisions"}],"predecessor-version":[{"id":17994,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/17991\/revisions\/17994"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/17992"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=17991"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=17991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}